» Articles » PMID: 10660562

Cloning and Functional Identification of a Neuronal Glutamine Transporter

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Feb 8
PMID 10660562
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamine is the preferred precursor for the neurotransmitter pool of glutamate, the major excitatory transmitter in the mammalian central nervous system. We have isolated a complementary DNA clone (designated GlnT) encoding a plasma membrane glutamine transporter from glutamatergic neurons in culture, and its properties have been examined using the T7 vaccinia system in fibroblasts. When GlnT is transfected into CV-1 cells, L-glutamine is the preferred substrate. Transport is Na(+)-dependent and inhibited by alpha-methylaminoisobutyric acid, a specific inhibitor of neutral amino acid transport system A. Kinetic analysis of glutamine uptake by GlnT is saturable, with a Michaelis constant (K(m)) of 489 +/- 88 microM at pH 7.4. Glutamine uptake mediated by GlnT is pH-sensitive with a 5-fold greater efficiency of uptake at pH 8.2 than at pH 6.6. Only the maximal velocity of transport increases without a significant change in K(m). The distribution of GlnT mRNA and protein in the central nervous system is widespread and is expressed on neurons that use glutamate as their neurotransmitter. In cultured cerebellar granule cells, GlnT is expressed only on neurons and is absent from astrocytes. GlnT expression increases concomitantly with the morphologic and functional differentiation of these cells in vitro, consistent with its role of supplying glutamatergic neurons with their neurotransmitter precursor. GlnT is the first member of the system A family of neutral amino acid transporters with 11 putative membrane-spanning domains and is a potential target to modulate presynaptic glutamatergic function.

Citing Articles

Astrocyte-Neuron Interaction via the Glutamate-Glutamine Cycle and Its Dysfunction in Tau-Dependent Neurodegeneration.

Sidoryk-Wegrzynowicz M, Adamiak K, Struzynska L Int J Mol Sci. 2024; 25(5).

PMID: 38474295 PMC: 10931567. DOI: 10.3390/ijms25053050.


Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches.

Jakobsen S, Nielsen C Pharmaceutics. 2024; 16(2).

PMID: 38399253 PMC: 10893028. DOI: 10.3390/pharmaceutics16020197.


Amino Acid Transporters Proteins Involved in the Glutamate-Glutamine Cycle and Their Alterations in Murine Models of Alzheimer's Disease.

Vazquez-Duran D, Ortega A, Rodriguez A Mol Neurobiol. 2024; 61(8):6077-6088.

PMID: 38273046 DOI: 10.1007/s12035-024-03966-3.


Ca-regulated expression of high affinity methylaminoisobutryic acid transport in hippocampal neurons inhibited by riluzole and novel neuroprotective aminothiazoles.

Erickson J, Kyllo T, Wulff H Curr Res Physiol. 2023; 6:100109.

PMID: 38107787 PMC: 10724208. DOI: 10.1016/j.crphys.2023.100109.


Importance of glutamine in synaptic vesicles revealed by functional studies of and its mutations pathogenic for intellectual disability.

Jia X, Zhu J, Bian X, Liu S, Yu S, Liang W Elife. 2023; 12.

PMID: 37440432 PMC: 10393021. DOI: 10.7554/eLife.86972.